Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.65 USD | +1.53% | -4.33% | -21.60% |
Sales 2024 * | - | Sales 2025 * | 329K 451K | Capitalization | 99.6M 137M |
---|---|---|---|---|---|
Net income 2024 * | -96M -132M | Net income 2025 * | -123M -169M | EV / Sales 2024 * | - |
Net cash position 2024 * | 43.16M 59.21M | Net cash position 2025 * | 178M 244M | EV / Sales 2025 * | -239 x |
P/E ratio 2024 * |
-1.22
x | P/E ratio 2025 * |
-1.14
x | Employees | 69 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 90.75% |
Latest transcript on Vigil Neuroscience, Inc.
1 day | +1.53% | ||
1 week | -4.33% | ||
Current month | +1.53% | ||
1 month | -19.45% | ||
3 months | -1.49% | ||
6 months | -61.93% | ||
Current year | -21.60% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 55 | 20-06-30 | |
Director of Finance/CFO | 50 | 20-06-30 | |
Kelly Neelon
CTO | Chief Tech/Sci/R&D Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 55 | 20-06-30 | |
Mary Thistle
BRD | Director/Board Member | 64 | 22-04-17 |
Cheryl Blanchard
BRD | Director/Board Member | 59 | 20-10-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.00% | 34 M€ | +1.32% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-01 | 2.65 | +1.53% | 46,194 |
24-04-30 | 2.61 | +0.38% | 39,199 |
24-04-29 | 2.6 | -4.06% | 68,569 |
24-04-26 | 2.71 | +5.04% | 46,561 |
24-04-25 | 2.58 | -6.86% | 66,727 |
Delayed Quote Nasdaq, May 01, 2024 at 04:00 pm
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-21.60% | 99.6M | |
+0.67% | 42.4B | |
+46.90% | 40.04B | |
-6.20% | 28.31B | |
+6.55% | 24.94B | |
-21.66% | 18.96B | |
+29.96% | 12.3B | |
-1.57% | 11.95B | |
+16.03% | 11.32B | |
-4.80% | 11.55B |
- Stock Market
- Equities
- VIGL Stock